Understanding GLP-1 Medications: Semaglutide vs. Tirzepatide

GLP-1 medications have become one of the biggest topics in healthcare, and increasingly, they're becoming part of conversations in the treatment room. As more clients begin medications like semaglutide and tirzepatide, skin professionals are noticing changes in facial volume, skin quality, and overall appearance.

While both medications are used to support blood sugar management and weight loss, they don't work exactly the same way. Understanding the science behind them can help you have more informed conversations with your clients.

What are GLP-1 medications?

GLP-1 stands for glucagon-like peptide-1, a hormone naturally produced in the gut after eating. GLP-1 helps regulate blood sugar, slows gastric emptying, and signals the brain that you're full, reducing appetite.

GIP (glucose-dependent insulinotropic polypeptide) is another naturally occurring hormone released by the small intestine after eating. Like GLP-1, it helps regulate blood sugar by stimulating insulin release when glucose levels rise. GIP also plays a role in energy metabolism and, when activated alongside GLP-1, may further enhance feelings of fullness and metabolic regulation.

Medications that target these hormone pathways have become effective treatment options for people living with type 2 diabetes and obesity, with some also approved for chronic weight management.

Key Differences

Semaglutide

  • Activates the GLP-1 receptor only.

  • Mimics one naturally occurring gut hormone involved in appetite and blood sugar regulation.

  • Slows gastric emptying, helping clients feel fuller for longer.

  • Commonly prescribed for type 2 diabetes and chronic weight management.

Tirzepatide

  • Activates both the GLP-1 and GIP receptors.

  • Mimics two naturally occurring gut hormones involved in appetite, insulin response, and energy metabolism.

  • May provide greater appetite suppression and improved metabolic regulation due to its dual mechanism of action.

  • Also prescribed for type 2 diabetes and chronic weight management

Why does this matter for skin professionals?

While these medications aren't prescribed for aesthetic purposes, significant weight loss, regardless of how it's achieved, can influence the skin.

Some clients may experience:

  • Facial volume loss

  • Increased skin laxity

  • More noticeable fine lines and wrinkles

  • Changes in facial contour

  • A greater need for long-term skin health strategies

It's important to remember that these changes are often related to the amount and rate of weight loss, rather than the medication itself. Not every client taking a GLP-1 medication will experience the same changes.

As professionals, our role isn't to evaluate whether a client should take these medications, that conversation belongs with their healthcare provider. Instead, we can recognize changes in the skin, adjust treatment plans when appropriate, and educate clients on supporting overall skin health throughout their journey.

Final Thoughts

Semaglutide and tirzepatide share many similarities, but they work through different biological pathways. As these medications become more common, understanding their mechanisms can help skin professionals better recognize potential changes they may observe in the treatment room and adapt their approach to support each client's evolving skin needs.